144534-62-3

Basic information

• Product Name: Silane, (3-cyclopenten-1-ylmethoxy)(1,1-dimethylethyl)dimethyl-
• CAS NO: 144534-62-3
• Molecular Formula: C12H24OSi
• Molecular Weight: 212.407
• Mol File: 144534-62-3.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Silane, (3-cyclopenten-1-ylmethoxy)(1,1-dimethylethyl)dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Silane, (3-cyclopenten-1-ylmethoxy)(1,1-dimethylethyl)dimethyl-(144534-62-3)
• EPA Substance Registry System: Silane, (3-cyclopenten-1-ylmethoxy)(1,1-dimethylethyl)dimethyl-(144534-62-3)

Safety Data

• Hazardous Substances Data: 144534-62-3(Hazardous Substances Data)

Upstream product

• 58101-60-3 methyl cyclopent-3-ene-1-carboxylate 
• 25125-21-7 4-(hydroxymethyl)cyclopentene 
• 18162-48-6 tert-butyldimethylsilyl chloride 

Downstream Products

• 852364-14-8 Toluene-4-sulfonic acid (1S,3S,5R)-1-(6-oxa-bicyclo[3.1.0]hex-3-yl)methyl ester 

Relevant articles and documents

Synthesis of a new exocyclic amino carbocyclic nucleoside with potential antiviral activity

The total synthesis of a new exocyclic amino carbocyclic nucleoside, (±)-(1),(±)-1′(β)-[4-(6-amino-5- nitro)pyrimidine-amino-2′-(α)-hydroxy-4′- hydroxymethylcyclopentane has been accomplished. 1-Hydroxymethyl-3- cyclopentene has been converted into a carbocyclic nucleoside in six steps.

TERTIARY ALCOHOL IMIDAZOPYRAZINE BTK INHIBITORS

Provided are Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, or their use in therapy.

CANNABINOID RECEPTOR MODULATORS

Disclosed are compounds of the formula: or the pharmaceutically acceptable salts or solvates thereof, wherein: Ar1 is a chlorophenyl group, Ar2 is a dichlorophenyl group, R1 is a--(CH2)m--X--(CH2)n--R2 group, X is a--NH--,--O--,--C(O)--or--S(O)2--group, and R2 is a substituted phenyl group. These compounds are CB1 receptor modulators. Also disclosed are methods of treating CB1 modulated diseases or conditions such as the metabolic syndrome.